Culture Biosciences has successfully completed its Series C funding round, raising significant capital to enhance its commercial operations. The round, which concluded on December 16, 2025, was led by existing investors, including Northpond Ventures, Synthesis Capital, S32, and Cultivian Sandbox. The strong backing from these shareholders underscores their confidence in Culture’s growth trajectory and long-term strategic vision.
The funds raised during this Series C round will be instrumental in accelerating the commercial rollout of Culture’s innovative hardware product, the Stratyx 250. This advanced system is designed to meet the evolving needs of the biomanufacturing industry, offering scalable, automated, and digitally connected bioprocess capabilities tailored for biologics, cell therapy, and advanced bioprocess development.
Additionally, the financing will support the ongoing development of Culture’s AI-powered Console software ecosystem. This software is integral to the company’s commitment to enhancing the efficiency and effectiveness of biomanufacturing processes. The integration of artificial intelligence into their platform aims to streamline operations, improve data analytics, and ultimately drive better outcomes for clients in the biomanufacturing sector.
Culture Biosciences, based in South San Francisco, California, has positioned itself as a leader in cloud-based biomanufacturing. The company focuses on leveraging technology to transform traditional bioprocessing methods, making them more efficient and accessible. The success of this funding round not only reflects the confidence investors have in Culture’s innovative approach but also highlights the growing demand for advanced biomanufacturing solutions in the global market.
As the company moves forward, the introduction of the Stratyx 250 and enhancements to its software platform are expected to play a pivotal role in meeting the increasing demands of the biopharmaceutical industry. By integrating cutting-edge technology with biomanufacturing processes, Culture aims to drive significant advancements in the field, positioning itself for sustained growth in the coming years.
